Experimental drug cuts risk of hospitalized COVID-19 patients needing a ventilator by 54%,
A new drug may help improve the conditions of severely ill coronavirus patients, new trial data suggest. Lenzilumab, developed by Humanigen Inc, has anti-inflammatory properties that scientists believe can control the immune system’s overreaction to the virus. When given in combination with other treatments, hospitalized patients were 54 percent more likely to survive without the … Read more